“Gajar Nouka”: an Exploratory Look Into Dhaka Middle Class' Youth's
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Report of the International Narcotics Control Board for 2015 (E/INCB/2015/1) Is Supple- Mented by the Following Reports
INTERNATIONAL NARCOTICS CONTROL BOARD REPORT REPORT 2015 INTERNATIONAL NARCOTICS CONTROL BOARD CONTROL NARCOTICS INTERNATIONAL Report 2015 EMBARGO Observe release date: Not to be published or broadcast before Wednesday, 2 March 2016, at 1100 hours (CET) UNITED NATIONS CAUTION Reports published by the International Narcotics Control Board in 2015 TheReport of the International Narcotics Control Board for 2015 (E/INCB/2015/1) is supple- mented by the following reports: Report of the International Narcotics Control Board on the Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes (E/INCB/2015/1/Supp.1) Narcotic Drugs: Estimated World Requirements for 2016—Statistics for 2014 (E/INCB/2015/2) Psychotropic Substances: Statistics for 2014—Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 (E/INCB/2015/3) Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances: Report of the International Narcotics Control Board for 2015 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2015/4) The updated lists of substances under international control, comprising narcotic drugs, psychotropic substances and substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, are contained in the latest editions of the annexes to the statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. Contacting the International Narcotics Control Board The secretariat of the Board may be reached at the following address: Vienna International Centre Room E-1339 P.O. -
National Strategic Framework on Health and Drugs a Comprehensive Approach to Address Health, Social and Legal Consequences of Drug Use in Myanmar
National Strategic Framework on Health and Drugs A Comprehensive Approach to Address Health, Social and Legal Consequences of Drug Use in Myanmar 2020 Contents FOREWORD 1 ACKNOWLEDGEMENTS 3 ACRONYMS 5 EXECUTIVE SUMMARY 7 INTRODUCTION 17 Rationale for the development of the National Strategic Framework on Health and Drugs 19 The scope of the NSF on Health and Drugs 20 Process for the development of the NSF 20 Geopolitical context of The Republic of the Union of Myanmar 21 Determinants of drug use 22 Overview of health, social and legal consequences of drug use 24 Prevalence and patterns of drug use in Myanmar 28 Overview of risk factors for HIV in Myanmar 29 Epidemiology of HIV, and coinfections with viral hepatitis and tuberculosis 31 Alignment of the NSF with international and regional resolutions and declarations 34 Alignment of the NSF with national policies, strategies and plans 36 Relevant sectors and ministries 39 STRATEGIC DIRECTION 1. PRIMARY PREVENTION OF DRUG USE 41 Definition and introduction 43 Effectiveness of prevention of drug use: global evidence 44 Prevention of drug use in Myanmar 46 Challenges and gaps in drug use prevention 49 RECOMMENDATIONS FOR THE STRATEGIC DIRECTION 1 51 STRATEGIC DIRECTION 2. HARM REDUCTION 57 Definition and introduction 59 Preventing injection drug use initiation 62 Addressing health consequences of drug use in Myanmar 63 Overview of the harm reduction response in Myanmar 64 Funding for HIV and harm reduction response 66 Implementation of the harm reduction response in Myanmar 67 Overview of the status of implementation of the comprehensive harm reduction package 68 Interventions aimed at preventing sexual transmission among PWID and their sexual partners 73 Harm reduction in prisons 75 Harm reduction in the context of ATS use 76 Drug use among women 78 Challenges and gaps in harm reduction 78 RECOMMENDATIONS FOR THE STRATEGIC DIRECTION 2 82 STRATEGIC DIRECTION 3. -
Fire and Ice: Conflict and Drugs in Myanmar’S Shan State
Fire and Ice: Conflict and Drugs in Myanmar’s Shan State Asia Report N°299 | 8 January 2019 Headquarters International Crisis Group Avenue Louise 149 • 1050 Brussels, Belgium Tel: +32 2 502 90 38 • Fax: +32 2 502 50 38 [email protected] Preventing War. Shaping Peace. Table of Contents Executive Summary ................................................................................................................... i I. Introduction ..................................................................................................................... 1 II. A Long Legacy ................................................................................................................... 3 III. A New Drug Dynamic ....................................................................................................... 6 A. A Surge in Production ................................................................................................ 6 B. Tip of the Iceberg ....................................................................................................... 10 IV. The Links Between Drugs and Conflict ............................................................................ 12 A. Current Conflict Dynamics ........................................................................................ 12 B. The Role of the Drug Trade in the Conflict................................................................ 13 C. Ethno-political Clashes, Anti-drug Raids or Bank Heists? ....................................... 15 D. Why Is There Not -
PDF (Drug Policy and the Sustainable Development Agenda)
POSITION PAPER DRUG POLICY AND THE SUSTAINABLE DEVELOPMENT AGENDA September 2018 KOFI ANNAN (IN MEMORIAM) JOYCE BANDA PAVEL BÉM RICHARD BRANSON FERNANDO HENRIQUE Chairman of the Kofi Annan Former President of Malawi Former Mayor of Prague, Entrepreneur, founder of the CARDOSO Foundation and Former Czech Republic Virgin Group,co-founder of Former President of Brazil Secretary-General of the The Elders, United Kingdom (Founding Chair) United Nations, Ghana MARIA CATTAUI HELEN CLARK NICK CLEGG RUTH DREIFUSS (CHAIR) CESAR GAVIRIA Former Secretary-General Former Prime Minister of New Former Deputy Former President of Former President of Colombia of the International Chamber Zealand and Administrator of Prime Minister of the Switzerland (Chair) of Commerce, Switzerland the United Nations United Kingdom Development Programme ANAND GROVER MICHEL KAZATCHKINE ALEKSANDER KWASNIEWSKI RICARDO LAGOS OLUSEGUN OBASANJO Former UN Special Rapporteur Former Executive Director of Former President of Poland Former President of Chile Former President of Nigeria on the right to health, India the Global Fund to Fight AIDS, Tuberculosis and Malaria, France GEORGE PAPANDREOU JOSÉ RAMOS-HORTA JORGE SAMPAIO GEORGE SHULTZ JAVIER SOLANA Former Prime Minister of Former President of Timor-Leste Former President of Portugal Former Secretary of State of Former European Union Greece the United States of America High Representative for the (Honorary Chair) Common Foreign and Security Policy, Spain MARIO VARGAS2 LLOSA PAUL VOLCKER ERNESTO ZEDILLO Writer and public intellectual, -
The Death Penalty for Drug Offences: Global Overview 2018
The Death Penalty for Drug Offences: Global Overview 2018 FEBRUARY 2019 Giada Girelli HARM REDUCTION INTERNATIONAL www.hri.global 2 Harm Reduction International The Death Penalty for Drug Offences: Global Overview 2018 3 The Death Penalty for Drug Offences: Global Overview 2018 Giada Girelli © Harm Reduction International, 2019 ISBN 978-0-9935434-8-7 Copy-edited by Richard Fontenoy Designed by Mark Joyce Published by Harm Reduction International 61 Mansell Street, Aldgate, London E1 8AN Telephone: +44 (0)20 7324 3535 E-mail: [email protected] Website: www.hri.global Harm Reduction International is a leading non-governmental organisation dedicated to reducing the negative health, social and legal impacts of drug use and drug policy. We promote the rights of people who use drugs and their communities through research and advocacy to help achieve a world where HARM REDUCTION drug policies and laws contribute to healthier, safer societies. INTERNATIONAL This publication has been produced with the financial support of the European Union. The contents of this publication are the sole responsibility of Harm Reduction International and can under no circumstances be regarded as reflecting the position of the European Union. Acknowledgements This report would not be possible without data made available or shared by leading human rights organisations and individual experts, with many of them also providing advice and assistance throughout the drafting process. We would specifically like to thank: the Institute for Criminal Justice Reform, Amnesty -
The History, Clinical Presentation, and Management of Party Drug Misuse
CHAPTER TEN “Addicted to Euphoria”: The History, Clinical Presentation, and Management of Party Drug Misuse Jenny Bearn*,†,1, Matthew O'Brien* *Addictions Clinical Academic Group, South London and Maudsley NHS Foundation Trust, Maudsley Hospital, London, United Kingdom †Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, United Kingdom 1Corresponding author: e-mail address: [email protected] Contents 1. Historical Aspects of Party Drug Use 206 1.1 3,4-Methylenedioxymethamphetamine 206 1.2 γ-Hydroxybutyric Acid 208 1.3 Ketamine 210 2. Epidemiology of Party Drug Use 211 3. Recreational Use Versus Dependence 212 4. Party Drugs: Subjective Effects and Hazards of use 214 4.1 MDMA (Ecstasy) 214 4.2 GHB and GBL 218 4.3 Ketamine 223 5. The Future of Party Drugs 228 References 228 Abstract Eating, drinking, sexual activity, and parenting invoke pleasure, an emotion that pro- motes repetition of these behaviors, are essential for survival. Euphoria, a feeling or state of intense excitement and happiness, is an amplification of pleasure, aspired to one's essential biological needs that are satisfied. People use party drugs as a shortcut to euphoria. Ecstasy (3,4- methylenedioxymethamphetamine), γ-hydroxybutyric acid, and ketamine fall under the umbrella of the term “party drugs,” each with differing neuropharmacological and physiological actions. This chapter seeks to survey the history and epidemiology of party drug use; we will then discuss the pharmacological characteristics of each drug to provide a platform for understanding the difficulties that party drug users encounter through intoxication, harmful use, dependence, and withdrawal and how these should be clinically managed. -
Global Overview 11
10 Global State of Harm Reduction 2018 1.1 Global Overview 11 Global Overview 1.1 Behind the Numbers 12 Global State of Harm Reduction 2018 1.1 Global Overview 13 Global Overview Behind the numbers This says nothing of one of the most pressing crises in harm reduction today – fatal drug-related overdose. It is a decade since Harm Reduction International North America and parts of Western Europe continue began compiling the Global State of Harm Reduction. to see overdose deaths climb, primarily those related While our coverage of harm reduction policies and to opioids and linked to polydrug use, while data in services has evolved and broadened in scope, the many regions fail to properly track these fatalities. same cannot always be said for harm reduction in Though naloxone – an opioid antagonist medicine that practice around the world. can reverse the effects of an overdose – is increasingly being deployed in the countries most affected by this According to a 2017 systematic review in the Lancet crisis, it is not always placed in the hands of those Global Health, injecting drug use is present in 179 of who need it most, i.e. people who use drugs and their 206 countries throughout the world, with HIV and peers. hepatitis C prevalence 17.8% and 52.3% respectively among the 15.6 million people who inject drugs.[2] Finally, as with the diversification of interventions based on drug used, different populations are better Despite this heavy burden of diseases, effective harm served by tailored approaches. This report notes, in reduction interventions that can help prevent their particular, the need for gender-sensitive services to spread are severely lacking in many countries. -
Cleveland-Winter Conference 2018
Cleveland-Winter Conference 2018 Position Papers for: World Health Organization Delegation from: People’s Republic of Bangladesh Represented by: Beachwood High School Committee: World Health Organizaiton Position Paper for the World Health Organization The issues before the World Health Organization are: Discussing the Safety of Healthcare Workers in Conflict Zones and Addressing the Universal Need to Prevent and Treat Substance Abuse. The People’s Republic of Bangladesh believes in furthering discussions regarding these issues and working towards resolutions which will prove both effective and long lasting. I. Discussing the Safety of Healthcare Workers in Conflict Zones The unjustifiable, rampant escalation of fatal attacks causing healthcare workers and civilians to become victims of horrific violence remains a vehement concern to the world. The violations of the safety and protection of healthcare workers worldwide has become a growing international concern, corresponding directly with a growth of terrorism and dishonest authority. Though the number of healthcare worker attacks has decreased from previous years, the number of weapons and methods which have been used to inflict terror upon innocent civilians has remained at a standstill. Despite the numerous resolutions that have been passed to mitigate the disturbing injustice experienced by healthcare workers in conflict zones, words of encouragement alone have not been enough. A recent UNGA resolution on Health Worker Protection affirmed that upholding, “the principles of humanity, neutrality, impartiality and independence in the provision of humanitarian assistance” is critical for, “humanitarian emergencies, armed conflicts and natural disasters.” Resources must be provided at local levels, and commitments must be secured from nations which are repeatedly experiencing attacks on healthcare centers. -
A Decade of Drug Policy a Civil Society Shadow Report - Executive Summary Taking Stock: a Decade of Drug Policy a Civil Society Shadow Report
TAKING STOCK: A DECADE OF DRUG POLICY A CIVIL SOCIETY SHADOW REPORT - EXECUTIVE SUMMARY TAKING STOCK: A DECADE OF DRUG POLICY A CIVIL SOCIETY SHADOW REPORT Taking stock: A decade of drug policy Funded by: Open Society Foundations Robert Carr Fund Partnership to Inspire, Transform and Connect the HIV response (PITCH) project Global Fund to Fight AIDS, Tuberculosis and Malaria Copy editing: Kay Bailey Graphics and design: Report design: Mathew Birch Cover design: Rudy Tun-Sánchez Figures and infographics: Juan Fernandez Ochoa, IDPC Printing: Printech Europe © International Drug Policy Consortium Publication 2018 Taking stock: A decade of drug policy Foreword on Drug Policy Global Commission Credit: Global drug control policies have been based on the general principles of eliminating the production, trade or use of any illegal psychoactive substance from the world. Yet policies which seek to reach that objective have involved harsh law-enforcement and even militarisation. These end up affecting the most vulnerable people who use drugs, subsistence farmers involved in illegal crop cultivation and small-scale traffickers because they are easier to apprehend than are wealthy and well-connected people. The collateral damages are human rights and lives – those of the most vulnerable and those of the voiceless. To quote the Deputy High Commissioner for Human Rights (May 2018), in a world that is meant to be more inclusive and where no one should be left behind, ‘people who use drugs Rt Hon Helen Clark are not left behind. They are left outside’. strategy for the next ten years. But how can we A decade ago, the international community plan the future without a serious and far-ranging reiterated its aspiration to achieve a drug-free assessment of the past’s errors and successes? How world. -
Healthcare in Prisons
1989–2019 GLOBAL YEARS PRISON TRENDS 2019 SPECIAL FOCUS Pull-out section Healthcare in prisons Global Prison Trends 2019 Penal Reform International The Thailand Institute of Justice (PRI) is an independent (TIJ) is a public organisation This document is co-published and non-governmental organisation established by the Government produced with financial assistance that develops and promotes of Thailand in 2011 and officially from the Thailand Institute of Justice fair, effective and proportionate recognised by the United Nations (TIJ). It is the fifth edition in Penal responses to criminal justice Office on Drugs and Crime as Reform International’s (PRI) Global problems worldwide. the latest member of the United Prison Trends series. Nations Crime Prevention and We promote alternatives to prison that This report was authored by Criminal Justice Programme support the rehabilitation of offenders, Vicki Prais and Frances Sheahan. Network Institutes in 2016. and promote the right of detainees The authors drew on information to fair and humane treatment. We One of the primary objectives of provided by contributors to PRI’s campaign for the prevention of torture the TIJ is to promote and support expert guest blog series available and the abolition of the death penalty, the implementation of the United at www.penalreform.org/blog and and we work to ensure just and Nations Rules for the Treatment of information kindly provided by appropriate responses to children and Women Prisoners and Non-custodial partner organisations. The report women who come into contact with Measures for Women Offenders was edited by Martha Crowley. the law. (the Bangkok Rules). -
Rise of Dollar Benefits Asian Expatriates
BUSINESS | 17 SPORT | 24 ATA Carnet to Amir Cup win at Khalifa bbecomee operational Stadium is ‘crowning from August 1 glory’ of Nam’s career Wednesday 23 May 2018 | 7 Ramadan I 1439 www.thepeninsula.qa Volume 23 | Number 7535 | 2 Riyals PM meets Australian Minister Amir checks Despite siege, Qatar on Palestinian gives healthcare to President’s health QNA DOHA: Amir H H Sheikh entire population Tamim bin Hamad Al Thani held a telephone conversation last evening with the Pres- THE PENINSULA Qatar continued providing ident of the State of Palestine healthcare services to Mahmoud Abbas to check on the entire population, DOHA: Minister of Public Health, his health. including the citizens H E Dr Hanan Mohamed Al of the countries of the During the phone call the Kuwari has stressed that the blockade, based on our Amir wished Abbas speedy unjust blockade imposed on the absolute belief that health recovery and good health and State of Qatar since June 2017 is was a basic human right, wellness. contrary to international conven- and human rights should tions. not be affected by political “Although the blockade differences, Minister of suddenly targeted having Public Health, H E Dr impact on citizens in food and Hanan Mohamed Al Kuwari Prime Minister and Interior Minister H E Sheikh Abdullah bin Nasser bin Khalifa Al Thani with Australian medicine but our country said at the 71st session Minister for Agriculture and Water Resources, David Littleproud. They discussed aspects of joint worked to overcome this through of the World Health cooperation and means of supporting and strengthening them in various fields. -
Human Performance Drug Fact Sheets
NATIONAL HIGHWAY TRAFFIC SAFETY ADMINISTRATION Drugs and Human Performance Fact Sheets Technical Report Documentation Page 1. Report No. 2. Government Accession No. 3. Recipient's Catalog No. DOT HS 809 725 4. Title and Subtitle 5. Report Date Drugs and Human Performance Fact Sheets April 2004 6. Performing Organization Code 7. Author(s) 8. Performing Organization Report No. COUPER, Fiona J. and LOGAN, Barry K 9. Performing Organization Name and Address 10. Work Unit No. (TRAIS) Washington State PatrolForensic Laboratory Services Bureau 2203 Airport Way S., Seattle, WA 98134 11. Contract or Grant No. 12. Sponsoring Agency Name and Address’ 13. Type of Report and Period Covered National Highway Traffic Safety Administration Final Report; 400 Seventh St., SW. August 2000-March 2004 Washington, DC 20590 14. Sponsoring Agency Code 15. Supplementary Notes The following toxicologists made significant contributions to both the drafting and review of the Fact Sheets: Michael Corbett Ph.D., Laurel Farrell MS., Marilyn Huestis Ph.D., Wayne Jeffrey MS, and Jan Raemakers, Ph.D. James F.Frank Ph.D. served as the NHTSA Contracting Officer's Technical Representative. 16. Abstract A panel of international experts on drug-impaired driving met in Seattle during August 2000 to review developments in the field of drugs and human performance over the last 10 years; to identify the specific effects that both illicit and prescription drugs have on driving; and to develop guidance for others when dealing with drug-impaired driving problems. Delegates represented the fields of psychopharmacology, behavioral psychology, drug chemistry, forensic toxicology, medicine, and law enforcement experts trained in the recognition of drug effects on drivers in the field.